Mackenzie Financial Corp Invests $113,000 in Aurora Cannabis Inc. (NASDAQ:ACB)

Mackenzie Financial Corp purchased a new stake in Aurora Cannabis Inc. (NASDAQ:ACB) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 24,410 shares of the company’s stock, valued at approximately $113,000.

Several other hedge funds and other institutional investors have also modified their holdings of the business. Virtu Financial LLC acquired a new position in shares of Aurora Cannabis in the 1st quarter valued at about $727,000. TD Asset Management Inc bought a new position in Aurora Cannabis during the second quarter valued at about $255,000. Headlands Technologies LLC bought a new stake in shares of Aurora Cannabis during the 1st quarter worth about $166,000. Concurrent Investment Advisors LLC bought a new position in shares of Aurora Cannabis in the 1st quarter valued at approximately $90,000. Finally, Toronto Dominion Bank grew its holdings in Aurora Cannabis by 34,356.4% during the second quarter. Toronto Dominion Bank now owns 18,951 shares of the company’s stock valued at $88,000 after purchasing an additional 18,896 shares during the last quarter. Institutional investors and hedge funds own 47.63% of the company’s stock.

Aurora Cannabis Price Performance

Shares of Aurora Cannabis stock opened at $5.35 on Tuesday. The company has a current ratio of 3.76, a quick ratio of 2.03 and a debt-to-equity ratio of 0.08. The firm has a fifty day simple moving average of $6.00 and a 200-day simple moving average of $6.02. The stock has a market capitalization of $291.82 million, a price-to-earnings ratio of -3.82 and a beta of 1.86. Aurora Cannabis Inc. has a 1-year low of $2.84 and a 1-year high of $9.35.

Aurora Cannabis (NASDAQ:ACB) last released its quarterly earnings results on Wednesday, August 7th. The company reported ($0.11) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.35) by $0.24. The company had revenue of $67.27 million during the quarter, compared to analysts’ expectations of $55.98 million. Aurora Cannabis had a negative net margin of 14.46% and a negative return on equity of 7.00%. On average, sell-side analysts expect that Aurora Cannabis Inc. will post -0.37 earnings per share for the current year.

About Aurora Cannabis

Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.